Nanoviricides (NNVC) Deferred Taxes (2011)
Nanoviricides' (NNVC) quarterly Deferred Taxes came in at $35417.0 in Q1 2011.
Powered by 
Analysis
Nanoviricides (NNVC) Deferred Taxes (2011) Analysis & Trends
Nanoviricides has disclosed Deferred Taxes across 1 years of filings, most recently posting $35417.0 for Q1 2011.
- In Q1 2011, Deferred Taxes changed N/A year-over-year to $35417.0; the TTM figure through Jun 2012 stood at $35417.0 (changed N/A YoY), while the FY2011 annual figure was $22917.0, up 136.77% from the prior year.
- Deferred Taxes came in at $35417.0 for Q1 2011 at Nanoviricides.
- In the past five years, Deferred Taxes ranged from a high of $35417.0 in Q1 2011 to a low of $35417.0 in Q1 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | -291.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -587.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -69.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 194.40 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.66 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -27.60 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Nanoviricides | 22.04 Mn | 18.83 Mn | - | - |